Simple Sugar may Help Fight Cancer

Glucose, commonly referred to as a 'simple' sugar, may actually be crucial in the fight against cancer and inflammatory disease.

Glucose, which is generated from the food that we eat, is the most important fuel used in our bodies as our cells use it to generate energy and for growth and division. Sugar doesn't make cancer grow faster. All cells, including cancer cells, depend on blood sugar (glucose) for energy.

Glucose - commonly referred to as a 'simple' sugar - may actually be crucial in the fight against cancer and inflammatory disease as scientists have just discovered a new role in which it stimulates cells that work on the front line in the fight against tumours and infection.

Frequent Emergency Department Visits of Cancer Patients can be Avoided
Patients suffering from cancer visit emergency department (ED) due to pain and get admitted there, but many times these admissions could be prevented, shows research.

‘Sugar essentially feeds tumors and encourages cancer growth. Cancer cells uptake sugar at 10-12 times the rate of healthy cells.’

The cells of our immune system become very active during an immune response, such as when responding to infection, and as a result they tend to have high demands for glucose. Unsurprisingly, when immune cells are starved of glucose, as might occur within tumours for instance, they become dysfunctional.

However, new research led by scientists at Trinity College Dublin shows that the immune cells that monitor our bodies for signs of danger (dendritic cells) are different -- when they are starved of glucose they actually become better at stimulating the vital players in the immune response (T lymphocytes).

The scientists believe this opens the door to new therapeutic possibilities to regulate immune responses to cancers and other immune-related diseases.

HPV Infections may Progress to Cervical Pre-Cancer in HIV Women
Human papillomavirus infection could progress to cervical pre-cancer in HIV women, finds a new study.

Ussher Assistant Professor in Cancer Biology, David Finlay, led the team whose work has just been published in leading international journal, Nature Communications.

Dr Finlay said: "It is becoming clear that glucose is an important signaller in our immune system, in that cells that have access to glucose behave very differently to those that do not. We have discovered that dendritic cells are actually better at stimulating immune responses when starved of glucose, which is not the case for any of the other immune cells that have been analysed."

Radiation Therapy for Head, Neck Cancer Patients Improved
Researchers at Moffitt have developed a test called the radiosensitivity index. This test determines how a patient's tumor is sensitive to radiation therapy.

"The discovery that T cells and dendritic cells compete with each other for glucose offers a new and exciting insight into how glucose can regulate dendritic cell function. We hope that by better understanding how nutrients such as glucose control the immune response, we can go on to develop new therapies to tackle a host of debilitating immune-related diseases."

Source-Eurekalert

New Technology For Early Stage Breast Cancer Developed
cerenkov luminescence imaging (CLI), a high-resolution and small-sized imaging equipment, is a possible solution for breast tumor surgery.